Cargando…
Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis
BACKGROUND: Neglected parasitic diseases (NTDs) like cutaneous leishmaniasis (CL) have caused high mortality and morbidity rate in developing countries. This disease is considered as one of the six major tropical diseases, and has a great importance in HIV infected individuals as an opportunistic in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957141/ https://www.ncbi.nlm.nih.gov/pubmed/31929528 http://dx.doi.org/10.1371/journal.pntd.0007843 |
_version_ | 1783487265465434112 |
---|---|
author | Badirzadeh, Alireza Heidari-Kharaji, Maryam Fallah-Omrani, Vahid Dabiri, Hossein Araghi, Atefeh Salimi Chirani, Alireza |
author_facet | Badirzadeh, Alireza Heidari-Kharaji, Maryam Fallah-Omrani, Vahid Dabiri, Hossein Araghi, Atefeh Salimi Chirani, Alireza |
author_sort | Badirzadeh, Alireza |
collection | PubMed |
description | BACKGROUND: Neglected parasitic diseases (NTDs) like cutaneous leishmaniasis (CL) have caused high mortality and morbidity rate in developing countries. This disease is considered as one of the six major tropical diseases, and has a great importance in HIV infected individuals as an opportunistic infection in those areas that both infections are endemic. This study evaluated the therapeutic effects of the Urtica dioica L (U. dioica) aqueous extract as an anti-leishmanial herbal drug in-vitro and in-vivo, and in addition to that, evaluated two vital immune system cytokines including gamma interferon (IFN-γ) and interleukin-4 (IL-4) plus nitric oxide (NO) and arginase activity against Leishmania major (L. major) infected mice. METHODOLOGY/PRINCIPAL FINDINGS: In-vitro anti-leishmanial activity of U. dioica aqueous extract was determined using MTT method and also Parasite Rescue Transformation Assay. Also, the footpad lesion size and parasite load in BALB/c mice infected with L. major were quantified for in-vivo assessment. Furthermore, for evaluating the immune responses, the levels of IFN-γ, IL-4, NO and arginase were measured in the BALB/c mice. These results indicated that U. dioica extract significantly reduced the L. major promastigotes viability. According to the in-vitro cytotoxicity assay of the extract on Leishmania parasites (CC50) and infected macrophages (EC50), the extract had no toxicity to the macrophages, however it efficiently killed the L. major amastigotes. In addition, the lesion size, parasite load, IL-4, and ARG were decreased in the treated infected mice, however IFN-γ and NO were significantly increased. CONCLUSIONS/SIGNIFICANCE: This study established satisfactory results in Leishmania parasite clearing both in-vivo and in-vitro. Therefore, U. dioica extract can be considered as an effective and harmless herbal compound for killing the parasite without toxicity to the host macrophages. Furthermore, it also can treat the CL by switching the mouse immune response towards a cell-mediated response (Th1); hence, it may be identified as a perfect therapeutic herbal drug for CL treatment. |
format | Online Article Text |
id | pubmed-6957141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-69571412020-01-26 Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis Badirzadeh, Alireza Heidari-Kharaji, Maryam Fallah-Omrani, Vahid Dabiri, Hossein Araghi, Atefeh Salimi Chirani, Alireza PLoS Negl Trop Dis Research Article BACKGROUND: Neglected parasitic diseases (NTDs) like cutaneous leishmaniasis (CL) have caused high mortality and morbidity rate in developing countries. This disease is considered as one of the six major tropical diseases, and has a great importance in HIV infected individuals as an opportunistic infection in those areas that both infections are endemic. This study evaluated the therapeutic effects of the Urtica dioica L (U. dioica) aqueous extract as an anti-leishmanial herbal drug in-vitro and in-vivo, and in addition to that, evaluated two vital immune system cytokines including gamma interferon (IFN-γ) and interleukin-4 (IL-4) plus nitric oxide (NO) and arginase activity against Leishmania major (L. major) infected mice. METHODOLOGY/PRINCIPAL FINDINGS: In-vitro anti-leishmanial activity of U. dioica aqueous extract was determined using MTT method and also Parasite Rescue Transformation Assay. Also, the footpad lesion size and parasite load in BALB/c mice infected with L. major were quantified for in-vivo assessment. Furthermore, for evaluating the immune responses, the levels of IFN-γ, IL-4, NO and arginase were measured in the BALB/c mice. These results indicated that U. dioica extract significantly reduced the L. major promastigotes viability. According to the in-vitro cytotoxicity assay of the extract on Leishmania parasites (CC50) and infected macrophages (EC50), the extract had no toxicity to the macrophages, however it efficiently killed the L. major amastigotes. In addition, the lesion size, parasite load, IL-4, and ARG were decreased in the treated infected mice, however IFN-γ and NO were significantly increased. CONCLUSIONS/SIGNIFICANCE: This study established satisfactory results in Leishmania parasite clearing both in-vivo and in-vitro. Therefore, U. dioica extract can be considered as an effective and harmless herbal compound for killing the parasite without toxicity to the host macrophages. Furthermore, it also can treat the CL by switching the mouse immune response towards a cell-mediated response (Th1); hence, it may be identified as a perfect therapeutic herbal drug for CL treatment. Public Library of Science 2020-01-13 /pmc/articles/PMC6957141/ /pubmed/31929528 http://dx.doi.org/10.1371/journal.pntd.0007843 Text en © 2020 Badirzadeh et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Badirzadeh, Alireza Heidari-Kharaji, Maryam Fallah-Omrani, Vahid Dabiri, Hossein Araghi, Atefeh Salimi Chirani, Alireza Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis |
title | Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis |
title_full | Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis |
title_fullStr | Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis |
title_full_unstemmed | Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis |
title_short | Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis |
title_sort | antileishmanial activity of urtica dioica extract against zoonotic cutaneous leishmaniasis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957141/ https://www.ncbi.nlm.nih.gov/pubmed/31929528 http://dx.doi.org/10.1371/journal.pntd.0007843 |
work_keys_str_mv | AT badirzadehalireza antileishmanialactivityofurticadioicaextractagainstzoonoticcutaneousleishmaniasis AT heidarikharajimaryam antileishmanialactivityofurticadioicaextractagainstzoonoticcutaneousleishmaniasis AT fallahomranivahid antileishmanialactivityofurticadioicaextractagainstzoonoticcutaneousleishmaniasis AT dabirihossein antileishmanialactivityofurticadioicaextractagainstzoonoticcutaneousleishmaniasis AT araghiatefeh antileishmanialactivityofurticadioicaextractagainstzoonoticcutaneousleishmaniasis AT salimichiranialireza antileishmanialactivityofurticadioicaextractagainstzoonoticcutaneousleishmaniasis |